Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics

Histopathology

Volumn 31, Issue 1, 1997, Pages 67-74

  Stewart, C J R ^a   Jeffers, M D ^b   Kennedy, A ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Inhibin; Neoplasm; Ovary

Indexed keywords

ADULT; ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEYDIG CELL; MAJOR CLINICAL STUDY; OVARY TUMOR; PRIORITY JOURNAL; SERTOLI CELL; SEX CORD TUMOR;

EID: 0030844468     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1997.5780819.x     Document Type: Article

References (35)

1. Koonings PP, Campbell K, Mishell DR, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10 year review. Obstet. Gynecol. 1989: 74; 921-926.
2. Fox H. Sex cord-stromal tumours of the ovary. J. Pathol. 1985: 145: 127-148.
3. Young RH, Scully RE. Ovarian sex cord-stromal tumors. Problems in differential diagnosis. Pathol. Annu. 1988: 23; 237-296.
4. Gordon MD, Ireland K. New developments in sex cord-stromal and germ cell tumors of the ovary. Clin. Lab. Med. 1995: 15; 595-610.
5. Young RH. Ovarian tumors other than those of surface epithelial-stromal type. Hum. Pathol. 1991: 22; 763-775.
6. Dickersin GR, Kline IW. Scully RE. Small cell carcinoma of the ovary with hypercalcaemia. A report of 11 cases. Cancer 1982; 49: 188-197.
7. Ulbright TM, Roth LM. Secondary tumors of the ovary. In Roth LM, Czernobilsky B eds. Tumors and Tumorlike Conditions of the Ovary. New York: Churchill Livingstone. 1985: 129-152.
8. Young RH, Prat J, Scully RE. Endometrioid stromal sarcomas of the ovary. A clinicopathologic analysis of 23 cases. Cancer 1984: 53; 1143-1155.
9. Gershenson DM, Morris M. Burke TW. Levenback C. Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide and cisplatin. Obstet. Gynecol. 1996: 87: 527-531.
10. Costa MJ, DeRose PB, Roth LM, Brescia RJ, Zaloudek CJ, Cohen C. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value. Hum. Pathol. 1994; 25; 60-66.
11. Otis CN, Powell JL, Barbuto D. Carcangiu ML. Intermediate lilamentous proteins in adult granulosa cell tumors. An immunohistochemical study of 25 cases. Am. J. Surg. Pathol. 1992; 16; 962-968.
12. Gitsch G, Kohlberger P, Steiner A, Neumeister B, Breitenecker G. Expression of cytokeratins in granulosa cell tumors and ovarian carcinomas. Aach. Gynecol. Obstet. 1992; 251; 193-197.
13. Aguirre P, Thor AD, Scully RE. Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings. Am. J. Clin. Pathol. 1989; 92; 140-149.
14. Costa MJ, Morris RJ, Wilson R. Judd R, Utility of immunohistochemistry in distinguishing ovarian Sertoli-stromal cell tumors from carcinosarcomas. Hum. Pathol 1992; 23; 787-797.
15. Santini D, Ceccarelli C. Leone O et al. Smooth muscle differentiation in normal human ovaries, ovarian stromal hyperplasia and ovarian granulosa-stromal cells tumors. Mod. Pathol. 1995; 8; 25-30.
16. Shaw JA, Dabbs DJ. Geisinger KR. Sclerosing stromal tumor of the ovary: an ultrastructural and immunohistochemical analysis with histogenetic considerations. Ultrastruct. Pathol. 1992; 16; 363-377.
17. Seidman JD, Abbondanzo SL. Bratthauer GL. Lipid cell (steroid cell) tumor of the ovary: immunophenotype with analysis of potential pitfall due to endogenous biotin-like activity. Int. J. Gynecol. Pathol. 1995; 14; 331-338.
18. Gurusinghe CJ, Healy DL, Jobling T, Mamers P, Burger HG. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol. Oncol. 1995; 57; 27-32.
19. Flemming P, Wellmann A, Maschek H, Lang H, Georgii A. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. Am. J. Surg. Pathol. 1995; 19; 927-933.
20. Flemming P, Grothe W, Maschek H, Petry KU, Wellmann A, Georgii A. The site of inhibin production in ovarian neoplasms. Histopathology 1996; 29; 465-468.
21. De Jong FH, Grootenhuis AJ, Klaij IA. Van Beurden WMO. Inhibin and related proteins: localization. regulation and effects. In Porter JC. Jezova D eds. Circulating Regulatory Factors and Neuroendocrinc Function. New York: Plenum Press, 1990: 271-93.
22. Jobling T, Mamers P, Healy DL et al. A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol. Oncol. 1994; 55; 285-289.
23. Burger HG, Robertson DM. Cahir N et al. Characterisation of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Clin. Endocrinol. 1996; 44; 413-418.
24. Wallace EM, Healy DL. Inhibins and activins: roles in clinical practice. Br. J. Obstet. Gynaecol. 1996; 103; 945-956.
25. Seidman JD. Unclassified ovarian gonadal stromal tumors. A clinicopathologic study of 32 cases. Am. J. Surg. Pathol. 1996; 20; 699-706.
26. Roth LM, Liban E, Czernobilsky B. Ovarian endometrioid tumors mimicking Sertoli and Sertoli-Leydig cell tumors. Sertoliform variant of endometrioid carcinoma. Cancer 1982; 50; 1322-1331.
27. Tornos C, Silva EG, Ordonez NG, Gershenson DM, Young RH. Scully RE. Endometriod carcinoma of the ovary with a prominent spindle-cell component, a source of diagnostic confusion. A report of 14 cases. Am. J. Surg. Pathol. 1995; 19; 1343-1353.
28. McLachlan RI, Robertson DM, DeKretser DM, Burger HG. Advances in the physiology of inhibin and inhibin-related peptides. Clin. Endocrinol. 1988; 29; 77-114.
29. Cooke I, O'Brien M, Charnock FM, Groome N. Ganesan TS. Inhibin as a marker for ovarian cancer. Br. J. Cancer 1995; 71; 1046-1050.
30. Healy DL, Burger HG, Mamers P et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N. Engl. J. Med. 1993; 329; 1539-1542.
31. Ohashi M, Hasegawa Y, Haji M, Igarashi M, Nawato H. Production of immunoreactive inhibin by a virilizing ovarian tumour (Sertoli-Leydig tumour). clin. Endocrinol. 1990; 33; 613-618.
32. McCluggage WG, Sloan JM, Murnaghan M, White R. Gynandroblastoma of ovary with juvenile granulosa cell component and heterologous intestinal type glands. Histopathology 1996; 29; 253-257.
33. Young RH, Welch WR, Dickersin GR, Scully RE. Ovarian sex cord tumor with annular tubules. Review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 1982; 50; 1384-1402.
34. Telerman A, Germ cell tumors of the ovary. In Kurman RJ. ed. Blaustein's Pathology of the Female Genital Tract. New York: Springer-Verlag. 1995; 849-914.
35. Blaakaer J, Micic S, Morris ID et al. Immunoreactive inhibinproduction in post-menopausal women with malignant epithelial ovarian tumors. Eur. J. Obstet. Gynecol. Reprod. Biol. 1993; 52; 105-110.